Literature DB >> 1696827

Tumor angiogenesis: the role of oncogenes and tumor suppressor genes.

N Bouck1.   

Abstract

The progressive growth of solid tumors is strictly dependent on their ability to attract new blood vessels that will supply them with oxygen and essential nutrients. Although in experimental models a number of compounds are able to elicit such angiogenesis, under normal physiological conditions new vessel growth is tightly repressed. One consequence of the cascade of oncogene activation and tumor suppressor gene loss that produces a solid tumor must be the alleviation of this normal repression. Understanding how this is achieved may help to define the functions of oncogenes and suppressor genes that are relevant to tumorigenicity and may suggest novel therapeutic strategies.

Entities:  

Mesh:

Year:  1990        PMID: 1696827

Source DB:  PubMed          Journal:  Cancer Cells        ISSN: 1042-2196


  27 in total

Review 1.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

2.  Anti-angiogenesis as a new concept for the therapy of neovascular diseases.

Authors:  L Schweigerer
Journal:  Klin Wochenschr       Date:  1991-07-22

Review 3.  Establishing a link between oncogenes and tumor angiogenesis.

Authors:  R S Kerbel; A Viloria-Petit; F Okada; J Rak
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

Review 4.  Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling.

Authors:  S Patan
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

5.  Genistein, a dietary-derived inhibitor of in vitro angiogenesis.

Authors:  T Fotsis; M Pepper; H Adlercreutz; G Fleischmann; T Hase; R Montesano; L Schweigerer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

6.  Expression of E-selectin, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 in non-small-cell lung carcinoma.

Authors:  A J Staal-van den Brekel; F B Thunnissen; W A Buurman; E F Wouters
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

Review 7.  Treating cancer by inhibiting angiogenesis: new hopes and potential pitfalls.

Authors:  J Rak; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

Review 8.  Oncogenes as inducers of tumor angiogenesis.

Authors:  J Rak; J Filmus; G Finkenzeller; S Grugel; D Marmé; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

9.  'Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma'.

Authors:  J L Orgaz; O Ladhani; K S Hoek; A Fernández-Barral; D Mihic; O Aguilera; E A Seftor; A Bernad; J L Rodríguez-Peralto; M J C Hendrix; O V Volpert; B Jiménez
Journal:  Oncogene       Date:  2009-09-21       Impact factor: 9.867

10.  Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy.

Authors:  M Matsuoka; N Ogata; T Otsuji; T Nishimura; K Takahashi; M Matsumura
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.